Ken Zhou

Ken Zhou joined EQT Partners as an Associate in September 2014. Ken started in the Stockholm office, and transferred to New York in 2019.

At EQT, Ken is focused on healthcare investing, and has been involved with EQT's investments in Parexel, Aldevron, Clinical Innovations, and Piab.

Prior to joining EQT Partners, Ken worked at McKinsey & Company in Stockholm.

Ken holds a B.Sc. in Business and Economics from the Stockholm School of Economics and an MBA from Harvard Business School.